Dr Israel Bendit
Current affiliation: University of Sao Paulo
Subject: Health Sciences
Primary location: Brazil
Quantification of imatinib in human serum: validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug mon...
Published in:Drug Design Development and Therapy
Publication date:2013-08-01
Molecular phenotype of a pediatric small round cell tumor
Published in:Cancer
Publication date:1990-10-01
N-myc oncogene expression and amplification in metastatic lesions of stage IV-S neuroblastoma
Published in:Cancer
Publication date:1990-06-01
Complete response to imatinib mesylate treatment in a 12-month-old patient with chronic myeloid leukemia
Published in:Pediatric Blood & Cancer
Publication date:2008-01-01
Concomitant p53 mutation and MYCN amplification in neuroblastoma
Published in:Medical and Pediatric Oncology
Publication date:1997-09-01
N-myc Oncogene Expression in Porcine Renal Development and Oncogenesis
Published in:Pediatric Research
Publication date:1991-03-01
Non-neoplastic bulky mediastinal mass presentation in an adolescent patient: a case report
Published in:Journal of Medical Case Reports
Publication date:2013-01-01
Ethnic Differences in Cerebral Venous Thrombosis
Published in:Cerebrovascular Diseases
Publication date:2005-01-01
Current patient management of chronic myeloid leukemia in Latin America
Published in:Cancer
Publication date:2010-07-21A study by the Latin American Leukemia Net (LALNET)
Mdm2 mRNA expression in salivary gland tumour cell lines
Published in:Journal of Oral Pathology and Medicine
Publication date:2004-02-01
Growth Hormone and Insulin-like Growth Factor I Axis and Growth of Children With Different Sickle Cell Anemia Haplotypes
Published in:Journal of Pediatric Hematology/Oncology
Publication date:2001-08-01
Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission
Published in:BMC Blood Disorders
Publication date:2010-01-01
Early Detection of t(8;21) Chromosomal Translocations During Treatment of PML-RARA Positive Acute Promyelocytic Leukemia: A Case Study
Published in:Clinical Medicine Insights Oncology
Publication date:2010-12-01
Efficacy and Tolerability after Unusually Low Doses of Dasatinib in Chronic Myeloid Leukemia Patients Intolerant to Standard-Dose Dasatinib Therapy
Published in:Clinical Medicine Insights Oncology
Publication date:2010-12-01
Prognostic impact of MYCN, DDX1, TrkA, and TrkC gene transcripts expression in neuroblastoma
Published in:Pediatric Blood & Cancer
Publication date:2010-12-09
Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case s...
Published in:Journal of Hematology & Oncology
Publication date:2009-01-01
Further evidence for the lack of correlation between the breakpoint site within M-BCR and CML prognosis and for the occasional involvement of p53 i...
Published in:Cancer Genetics and Cytogenetics
Publication date:1995-10-01
Dasatinib Overrides Imatinib Resistance Mediated by the F359I Residue Mutation in Two Patients with Chronic Myeloid Leukemia
Published in:Acta Haematologica
Publication date:2012-01-01
Peripheral Blood c-erbB-2 Expression by Reverse Transcriptase—Polymerase Chain Reaction in Breast Cancer Patients Receiving Chemotherapy
Published in:Clinical Breast Cancer
Publication date:2002-08-01
Simultaneous detection of JAK2 V617F mutation and Bcr-Abl translocation in a patient with chronic myelogenous leukemia
Published in:International Journal of Hematology
Publication date:2008-07-16
Emergence of abnormal clone with monsomy 7 in Philadelphia negative cells of CML patients treated with tyrosine kinase inhibitors
Published in:International Journal of Hematology
Publication date:2008-12-18
Pretherapeutic Expression of the hOCT1 Gene Predicts a Complete Molecular Response to Imatinib Mesylate in Chronic-Phase Chronic Myeloid Leukemia
Published in:Acta Haematologica
Publication date:2012-01-01
Response to Dasatinib in a Patient with Concomitant Chronic Myeloid Leukemia and Chronic Lymphocytic Leukemia
Published in:Acta Haematologica
Publication date:2010-01-01
Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia
Published in:Leukemia Research
Publication date:1998-11-01
Interferon-alpha therapy increases type I insulin-like growth factor receptors expression on lymphoid cells from patients with chronic myelogenous ...
Published in:Leukemia Research
Publication date:2001-08-01
Simultaneous Occurrence of Biphenotypic T Cell/Myeloid Lesions Involving t(12;13)(p13;q14) in a Pediatric Patient
Published in:Acta Haematologica
Publication date:2012-01-01
Effects of selective bile duct ligation on liver parenchyma in young animals: histologic and molecular evaluations
Published in:Journal of Pediatric Surgery
Publication date:2012-03-01
CK-19 Expression by RT-PCR in the Peripheral Blood of Breast Cancer Patients Correlates with Response to Chemotherapy
Published in:Breast Cancer Research and Treatment
Publication date:2001-04-01
Atualização em leucemia mieloide crônica
Published in:Revista da Associação Médica Brasileira
Publication date:2013-07-01
Update on chronic myeloid leukemia
Published in:Revista da Associação Médica Brasileira (English Edition)
Publication date:2013-01-01
The Use of Imatinib Mesylate as a Lifesaving Treatment of Chronic Myeloid Leukemia Relapse after Bone Marrow Transplantation
Published in:Journal of Transplantation
Publication date:2009-01-01
Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy
Published in:Advances in Hematology
Publication date:2010-01-01
Evaluation of Long-Term Outcomes, Cytogenetic and Molecular Responses with Imatinib Mesylate in Early and Late Chronic-Phase Chronic Myeloid Leukem...
Published in:Acta Haematologica
Publication date:2012-01-01
Monitoração molecular da Leucemia Mielóide Crônica na era do imatinibe
Published in:Revista Brasileira de Hematologia e Hemoterapia
Publication date:2008-04-01
Efeitos adversos e resposta citogenética em pacientes com leucemia mieloide crônica tratados com imatinibe
Published in:Revista Brasileira de Hematologia e Hemoterapia
Publication date:2010-01-01